Origins, pathophysiology, diagnosis, vaccination and prevention of Chikungunya virus

1. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3(7):263.10.1371/journal.pmed.0030263Search in Google Scholar

2. Deller JJ, Russell PK. An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Inter Med. 1967;66(6):1129-43.10.7326/0003-4819-66-6-1129Search in Google Scholar

3. McGill PE. Viral infections: α-viral arthropathy. Best Prac & Res Clin Rheumat. 1995;9(1):145-50.10.1016/S0950-3579(05)80151-7Search in Google Scholar

4. Adebajo AO. Rheumatic manifestations of tropical diseases. Curr Opin Rheumatol. 1996;8(1):85-9.10.1097/00002281-199601000-00015Search in Google Scholar

5. Ligon BL. Reemergence of an unusual disease: the chikungunya epidemic. In Seminars in pediatric infectious diseases. WB Saunders. 2006:17(2):99-104.10.1053/j.spid.2006.04.009Search in Google Scholar

6. Yadav P, Gokhale MD, Barde PV, Singh DK, Mishra AC, Mourya DT. Experimental transmission of Chikungunya virus by Anopheles stephensi mosquitoes. Act Virol. 2003;47(1):45-7.Search in Google Scholar

7. Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lan Infect Dis. 2007;7(5):319-27.10.1016/S1473-3099(07)70107-XSearch in Google Scholar

8. Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med and Hyg. 1999;60(2):281-6.10.4269/ajtmh.1999.60.281Search in Google Scholar

9. Jupp PG. Chikungunya virus disease. Arbovirus: epidemiology and ecology. 1988:137.10.1201/9780429280245-7Search in Google Scholar

10. Ng LC, Hapuarachchi HC. Tracing the path of Chikungunya virus – evolution and adaptation. Infect Gen Evol. 2010;10(7):876-85.10.1016/j.meegid.2010.07.012Search in Google Scholar

11. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955;49(1):28-32.10.1016/0035-9203(55)90080-8Search in Google Scholar

12. Bandeira AC, Campos GS, Sardi SI, Rocha VF, Rocha GC. Neonatal encephalitis due to Chikungunya vertical transmission: first report in Brazil. ID Cases. 2016;5:57-9.10.1016/j.idcr.2016.07.008Search in Google Scholar

13. Khan AH, Morita K, del Carmen Parquet M, Hasebe F, Mathenge EG, Igarashi A. Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site. J Gen Virol. 2002;83(12):3075-84.10.1099/0022-1317-83-12-3075Search in Google Scholar

14. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol reviews. 1994;58(3):491-562.10.1128/mr.58.3.491-562.1994Search in Google Scholar

15. Yadav P, Shouche YS, Munot HP, Mishra AC, Mourya DT. Genotyping of Chikungunya virus isolates from India during 1963-2000 by reverse transcription-polymerase chain reaction. Act Virol. 2003;47(2):125.Search in Google Scholar

16. Vanlandingham DL, Hong C, Klingler K, Tsetsarkin K, McElroy KL, Powers AM, et al. Differential infectivities of o’nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2005;72(5):616-21.10.4269/ajtmh.2005.72.616Search in Google Scholar

17. Jupp PG, McIntosh BM, Dos Santos I, De Moor P. Laboratory vector studies on six mosquito and one tick species with chikungunya virus. Trans R Soc Trop Med Hyg. 1981;75(1):15-9.10.1016/0035-9203(81)90005-5Search in Google Scholar

18. Rao TR. Vectors of dengue and chikungunya viruses: a brief review. Ind J Med Res. 1964;52:719-26.Search in Google Scholar

19. R. C. Kading, E. M. Borland, M. Cranfield, A. M. Powers. Prevalence of antibod-ies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater congo basin. J Wildl Dis. 2013;49:587-599.10.7589/2012-08-212Search in Google Scholar

20. Lam SK, Chua KB, Hooi PS, Rahimah MA, Kumari S, Tharmaratnam M, et al. Chikungunya infection-an emerging disease in Malaysia. Southeast A J Trop Med Pub Health. 2001 Sep;32(3):447-51.Search in Google Scholar

21. Van den Bosch C. A role for RNA viruses in the pathogenesis of Burkitt’s lymphoma: the need for reappraisal. Adv Hematol. 2012; 2012.10.1155/2012/494758Search in Google Scholar

22. Borgherini G, Poubeau P, Staikowsky F, Lory M, Moullec NL, Becquart JP, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007 Jun 1;44(11): 1401-7.10.1086/517537Search in Google Scholar

23. Queyriaux B, Simon F, Grandadam M, Michel R, Tolou H, Boutin JP. Clinical burden of chikungunya virus infection. Lan Infect Dis. 2008;8(1):2-3.10.1016/S1473-3099(07)70294-3Search in Google Scholar

24. Lemant J, Boisson V, Winer A, Thibault L, André H, Tixier F, et al. Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005–2006. Crit care Med. 2008;36(9):2536-41.10.1097/CCM.0b013e318183f2d218679124Search in Google Scholar

25. Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, et al. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Med. 2007;86(3):123-37.10.1097/MD/0b013e31806010a517505252Search in Google Scholar

26. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3(3):e389.10.1371/journal.pntd.0000389264773419274071Search in Google Scholar

27. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 2010;104(6):392-9.10.1016/j.trstmh.2010.01.01120171708Search in Google Scholar

28. Brighton SW, Prozesky OW, De La Harpe AL. Chikungunya virus infection-A retrospective study of 107 cases. South Afr Med J. 1983;68(9):313-5.Search in Google Scholar

29. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis. 2008; 47(4):469-75.10.1086/59000318611153Search in Google Scholar

30. Thiberville SD, Boisson V, Gaudart J, Simon F, Flahault A, De Lamballerie X. Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis. 2013;7(1):e2004.10.1371/journal.pntd.0002004354784123350006Search in Google Scholar

31. Sissoko D, Ezzedine K, Moendandzé A, Giry C, Renault P, Malvy D. Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005–2006. Trop Med & Int Health. 2010;15(5):600-7.10.1111/j.1365-3156.2010.02485.x20214759Search in Google Scholar

32. Zim MM, Sam IC, Omar SS, Chan YF, AbuBakar S, Kamarulzaman A. Chikungunya infection in Malaysia: comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol. 2013;56(2):141-5.10.1016/j.jcv.2012.10.01923201456Search in Google Scholar

33. Staikowsky F, Talarmin F, Grivard P, Souab A, Schuffenecker I, Le Roux K, et al. Prospective study of Chikungunya virus acute infection in the Island of La Reunion during the 2005-2006 outbreak. PloS one. 2009;4(10):e7603.10.1371/journal.pone.0007603276404919893613Search in Google Scholar

34. Nkoghe D, Kassa RF, Caron M, Grard G, Mombo I, Bikié B, et al. Clinical forms of chikungunya in Gabon, 2010. PLoS Negl Trop Dis. 2012;6(2):e1517.10.1371/journal.pntd.0001517327951122348166Search in Google Scholar

35. Kimani J, Osanjo GO, Sang R, Ochieng J, Mulaa F. Development of Dromedary Antibody-based Enzyme Linked Immunosorbent Assay for Detecting Chikungunya virus Infections. Afr J Pharm Therap. 2017;6(2);109-16.Search in Google Scholar

36. Galo SS, González K, Téllez Y, García N, Pérez L, Gresh L, et al. Development of in-house serological methods for diagnosis and surveillance of chikungunya. Rev Panam de Sal Públ. 2017;41:e56.10.26633/RPSP.2017.56Search in Google Scholar

37. Agarwal A, Singh AK, Sharma S, Soni M, Thakur AK, Gopalan N, et al. Application of Real-time RT-PCR in vector surveillance and assessment of replication kinetics of an emerging novel ECSA genotype of Chikungunya virus in Aedes aegypti. J Virol Meth. 2013;193(2):419-25.10.1016/j.jviromet.2013.07.004Search in Google Scholar

38. Chen H, Takei F, Koay ES, Nakatani K, Chu JJ. A novel DANP-coupled hairpin RT-PCR for rapid detection of Chikungunya virus. J Mol Diagn. 2013;15(2):227-33.10.1016/j.jmoldx.2012.10.004Search in Google Scholar

39. Rueda JC, Angarita JI, Santos AM, Saldarriaga EL, Pelaez-Ballestas I, Lόpez-Morales P, et al. SAT0574 Performance of immunoglobulin M and G (IGM and IGG) antibodies against chikungunya virus (CHIKV) by enzyme-linked immunosorbent (ELISA) technique. Ann Rheum Dis. 2017;76:993.10.1136/annrheumdis-2017-eular.1886Search in Google Scholar

40. Smee DF, Alaghamandan HA, Kini GD, Robins RK. Antiviral activity and mode of action of ribavirin 5’-sulfamate against Semliki Forest virus. Antv Res. 1988;10(6):253-62.10.1016/0166-3542(88)90044-7Search in Google Scholar

41. Abdelnabi R, Neyts J, Delang L. Chikungunya virus infections: time to act, time to treat. Curr Opin Virol. 2017;24:25-30.10.1016/j.coviro.2017.03.01628414993Search in Google Scholar

42. Ravichandran R, Manian M. Ribavirin therapy for Chikungunya arthritis. J Infect Developing Countries. 2008;2(02):140-2.10.3855/T2.2.140Search in Google Scholar

43. Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination. Antv Res. 2004;61(2):111-7.10.1016/j.antiviral.2003.09.00514670584Search in Google Scholar

44. Guzzetta G, Trentini F, Poletti P, Baldacchino FA, Montarsi F, Capelli G, et als. Effectiveness and economic assessment of routine larviciding for prevention of chikungunya and dengue in temperate urban settings in Europe. PLoS Negl Trop Dis. 2017;11(9):e0005918.10.1371/journal.pntd.0005918560841528892499Search in Google Scholar

45. Powers AM. Vaccine and Therapeutic Options To Control Chikungunya Virus. Clin Mbio Reviews. 2018;31(1):e00104-16.10.1128/CMR.00104-16574097129237708Search in Google Scholar

46. Muthumani K, Block P, Flingai S, Muruganantham N, Chaaithanya IK, Tingey C, et al. Rapid and long-term immunity elicited by DNA-encoded antibody prophylaxis and DNA vaccination against chikungunya virus. J Infect Dis. 2016;214(3):369-78.10.1093/infdis/jiw111493664227001960Search in Google Scholar

47. Rowland RR, Yoo D. Nucleolar-cytoplasmic shuttling of PRRSV nucleocapsid protein: a simple case of molecular mimicry or the complex regulation by nuclear import, nucleolar localization and nuclear export signal sequences. Vir Res. 2003;95(1-2):23-33.10.1016/S0168-1702(03)00161-8Search in Google Scholar

48. Taylor A, Liu X, Zaid A, Goh LY, Hobson-Peters J, Hall RA, et al. Mutation of the n-terminal region of chikungunya virus capsid protein: Implications for vaccine design. Mbio. 2017;8(1): e01970-16.10.1128/mBio.01970-16Search in Google Scholar

49. Roques P, Ljungberg K, Kümmerer BM, Gosse L, Dereuddre-Bosquet N, Tchitchek N, et al. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus. JCI Ins. 2017;2(6);1-20.10.1172/jci.insight.83527Search in Google Scholar

50. Tangy F, Brandler S, Despres P, Habel A, inventors; THEMIS BIOSCIENCE GMBH, Institut Pasteur, Centre National de la Recherche Scientifique CNRS, assignee. Recombinant measles virus expressing Chikungunya virus polypeptides and their applications. United States patent US 9,655,961. 2017.Search in Google Scholar

51. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med. 2002;347(1):13-8.10.1056/NEJMoa011699Search in Google Scholar

52. Mirzaian E, Durham MJ, Hess K, Goad JA. Mosquito-Borne illnesses in travelers: a review of risk and prevention. Pharmtherap: J Human Pharm Drug Therap. 2010;30(10):1031-43.10.1592/phco.30.10.1031Search in Google Scholar

53. Nasci RS, Zielinski-Gutierrez E, Wirtz RA, Brogdon WG. Protection against mosquitoes, ticks, other insects and arthropods. 2014 (Yellow book).Search in Google Scholar

54. Patterson J, Sammon M, Garg M. Dengue, Zika and Chikungunya: emerging arboviruses in the new world. Westn J Emerg Med. 2016; 17(6):671.10.5811/westjem.2016.9.30904Search in Google Scholar

55. Chang LJ, Dowd KA, Mendoza FH, Saunders JG, Sitar S, Plummer SH, et al. Safety and tolerability of Chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lan. 2014; 384(9959):2046-52.10.1016/S0140-6736(14)61185-5Search in Google Scholar